Clinical Trial Site

Hiroshima

0 studies enrolling now · 2 studies all time

What they study most

ANCA-Associated Vasculitis, Amyloidosis

Studies at this site

• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran) — Completed